COVID-19 and cardiovascular complications: updates of emergency medicine
Abstract. Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and SARS-CoV-2 variants, has become a global pandemic resulting in significant morbidity and mortality. Severe cases of COVID-19 are characterized by hypoxemia, hyperinflammation, cy...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Health/LWW
2023-09-01
|
| Series: | Emergency and Critical Care Medicine |
| Online Access: | http://journals.lww.com/10.1097/EC9.0000000000000095 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850266269811474432 |
|---|---|
| author | Jianli Zhao Yaoli Xie Zhijun Meng Caihong Liu Yalin Wu Fujie Zhao Xinliang Ma Theodore A. Christopher Bernard J. Lopez Yajing Wang |
| author_facet | Jianli Zhao Yaoli Xie Zhijun Meng Caihong Liu Yalin Wu Fujie Zhao Xinliang Ma Theodore A. Christopher Bernard J. Lopez Yajing Wang |
| author_sort | Jianli Zhao |
| collection | DOAJ |
| description | Abstract. Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and SARS-CoV-2 variants, has become a global pandemic resulting in significant morbidity and mortality. Severe cases of COVID-19 are characterized by hypoxemia, hyperinflammation, cytokine storm in lung. Clinical studies have reported an association between COVID-19 and cardiovascular disease (CVD). Patients with CVD tend to develop severe symptoms and mortality if contracted COVID-19 with further elevations of cardiac injury biomarkers. Furthermore, COVID-19 itself can induce and promoted CVD development, including myocarditis, arrhythmia, acute coronary syndrome, cardiogenic shock, and venous thromboembolism. Although the direct etiology of SARS-CoV-2–induced cardiac injury remains unknown and underinvestigated, it is suspected that it is related to myocarditis, cytokine-mediated injury, microvascular injury, and stress-related cardiomyopathy. Despite vaccinations having provided the most effective approach to reducing mortality overall, an adapted treatment paradigm and regular monitoring of cardiac injury biomarkers is critical for improving outcomes in vulnerable populations at risk for severe COVID-19. In this review, we focus on the latest progress in clinic and research on the cardiovascular complications of COVID-19 and provide a perspective of treating cardiac complications deriving from COVID-19 in emergency medicine. |
| format | Article |
| id | doaj-art-52b3f2254ad14ab8b103e32ca0692c0c |
| institution | OA Journals |
| issn | 2097-0617 2693-860X |
| language | English |
| publishDate | 2023-09-01 |
| publisher | Wolters Kluwer Health/LWW |
| record_format | Article |
| series | Emergency and Critical Care Medicine |
| spelling | doaj-art-52b3f2254ad14ab8b103e32ca0692c0c2025-08-20T01:54:12ZengWolters Kluwer Health/LWWEmergency and Critical Care Medicine2097-06172693-860X2023-09-013310411410.1097/EC9.0000000000000095202309000-00004COVID-19 and cardiovascular complications: updates of emergency medicineJianli Zhao0Yaoli Xie1Zhijun Meng2Caihong Liu3Yalin Wu4Fujie Zhao5Xinliang Ma6Theodore A. Christopher7Bernard J. Lopez8Yajing Wang9a Emergency Medicine Department, Thomas Jefferson University, Philadelphia, PA, USAa Emergency Medicine Department, Thomas Jefferson University, Philadelphia, PA, USAa Emergency Medicine Department, Thomas Jefferson University, Philadelphia, PA, USAa Emergency Medicine Department, Thomas Jefferson University, Philadelphia, PA, USAb Department of Biomedical Engineering, University of Alabama at Birmingham, AL, USA.b Department of Biomedical Engineering, University of Alabama at Birmingham, AL, USA.a Emergency Medicine Department, Thomas Jefferson University, Philadelphia, PA, USAa Emergency Medicine Department, Thomas Jefferson University, Philadelphia, PA, USAa Emergency Medicine Department, Thomas Jefferson University, Philadelphia, PA, USAa Emergency Medicine Department, Thomas Jefferson University, Philadelphia, PA, USAAbstract. Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and SARS-CoV-2 variants, has become a global pandemic resulting in significant morbidity and mortality. Severe cases of COVID-19 are characterized by hypoxemia, hyperinflammation, cytokine storm in lung. Clinical studies have reported an association between COVID-19 and cardiovascular disease (CVD). Patients with CVD tend to develop severe symptoms and mortality if contracted COVID-19 with further elevations of cardiac injury biomarkers. Furthermore, COVID-19 itself can induce and promoted CVD development, including myocarditis, arrhythmia, acute coronary syndrome, cardiogenic shock, and venous thromboembolism. Although the direct etiology of SARS-CoV-2–induced cardiac injury remains unknown and underinvestigated, it is suspected that it is related to myocarditis, cytokine-mediated injury, microvascular injury, and stress-related cardiomyopathy. Despite vaccinations having provided the most effective approach to reducing mortality overall, an adapted treatment paradigm and regular monitoring of cardiac injury biomarkers is critical for improving outcomes in vulnerable populations at risk for severe COVID-19. In this review, we focus on the latest progress in clinic and research on the cardiovascular complications of COVID-19 and provide a perspective of treating cardiac complications deriving from COVID-19 in emergency medicine.http://journals.lww.com/10.1097/EC9.0000000000000095 |
| spellingShingle | Jianli Zhao Yaoli Xie Zhijun Meng Caihong Liu Yalin Wu Fujie Zhao Xinliang Ma Theodore A. Christopher Bernard J. Lopez Yajing Wang COVID-19 and cardiovascular complications: updates of emergency medicine Emergency and Critical Care Medicine |
| title | COVID-19 and cardiovascular complications: updates of emergency medicine |
| title_full | COVID-19 and cardiovascular complications: updates of emergency medicine |
| title_fullStr | COVID-19 and cardiovascular complications: updates of emergency medicine |
| title_full_unstemmed | COVID-19 and cardiovascular complications: updates of emergency medicine |
| title_short | COVID-19 and cardiovascular complications: updates of emergency medicine |
| title_sort | covid 19 and cardiovascular complications updates of emergency medicine |
| url | http://journals.lww.com/10.1097/EC9.0000000000000095 |
| work_keys_str_mv | AT jianlizhao covid19andcardiovascularcomplicationsupdatesofemergencymedicine AT yaolixie covid19andcardiovascularcomplicationsupdatesofemergencymedicine AT zhijunmeng covid19andcardiovascularcomplicationsupdatesofemergencymedicine AT caihongliu covid19andcardiovascularcomplicationsupdatesofemergencymedicine AT yalinwu covid19andcardiovascularcomplicationsupdatesofemergencymedicine AT fujiezhao covid19andcardiovascularcomplicationsupdatesofemergencymedicine AT xinliangma covid19andcardiovascularcomplicationsupdatesofemergencymedicine AT theodoreachristopher covid19andcardiovascularcomplicationsupdatesofemergencymedicine AT bernardjlopez covid19andcardiovascularcomplicationsupdatesofemergencymedicine AT yajingwang covid19andcardiovascularcomplicationsupdatesofemergencymedicine |